nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Anagrelide—hematologic cancer	0.109	0.217	CbGbCtD
Phenylephrine—CYP1A2—Carmustine—hematologic cancer	0.057	0.114	CbGbCtD
Phenylephrine—CYP1A2—Methoxsalen—hematologic cancer	0.0485	0.097	CbGbCtD
Phenylephrine—CYP1A2—Bortezomib—hematologic cancer	0.0461	0.0922	CbGbCtD
Phenylephrine—CYP1A2—Daunorubicin—hematologic cancer	0.0441	0.0882	CbGbCtD
Phenylephrine—CYP1A2—Alitretinoin—hematologic cancer	0.0432	0.0864	CbGbCtD
Phenylephrine—CYP1A2—Thalidomide—hematologic cancer	0.0402	0.0803	CbGbCtD
Phenylephrine—CYP1A2—Dacarbazine—hematologic cancer	0.0346	0.0691	CbGbCtD
Phenylephrine—CYP1A2—Imatinib—hematologic cancer	0.0338	0.0676	CbGbCtD
Phenylephrine—CYP1A2—Dasatinib—hematologic cancer	0.0271	0.0543	CbGbCtD
Phenylephrine—CYP1A2—Etoposide—hematologic cancer	0.0169	0.0338	CbGbCtD
Phenylephrine—Isoprenaline—PIK3R1—hematologic cancer	0.00309	0.662	CrCbGaD
Phenylephrine—Norepinephrine—SLC22A1—hematologic cancer	0.000617	0.132	CrCbGaD
Phenylephrine—Epinephrine—SLC22A1—hematologic cancer	0.00056	0.12	CrCbGaD
Phenylephrine—Epinephrine—TNF—hematologic cancer	0.000403	0.0862	CrCbGaD
Phenylephrine—Nausea—Bortezomib—hematologic cancer	0.000106	0.000273	CcSEcCtD
Phenylephrine—Loss of consciousness—Betamethasone—hematologic cancer	0.000106	0.000273	CcSEcCtD
Phenylephrine—Loss of consciousness—Dexamethasone—hematologic cancer	0.000106	0.000273	CcSEcCtD
Phenylephrine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Hypersensitivity—Irinotecan—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisolone—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Tachycardia—Triamcinolone—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Vomiting—Thiotepa—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—hematologic cancer	0.000106	0.000272	CcSEcCtD
Phenylephrine—Nausea—Bleomycin—hematologic cancer	0.000106	0.000271	CcSEcCtD
Phenylephrine—Rash—Thiotepa—hematologic cancer	0.000105	0.00027	CcSEcCtD
Phenylephrine—Dermatitis—Thiotepa—hematologic cancer	0.000105	0.00027	CcSEcCtD
Phenylephrine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000105	0.00027	CcSEcCtD
Phenylephrine—Headache—Thiotepa—hematologic cancer	0.000105	0.000268	CcSEcCtD
Phenylephrine—Hypertension—Dexamethasone—hematologic cancer	0.000105	0.000268	CcSEcCtD
Phenylephrine—Hypertension—Betamethasone—hematologic cancer	0.000105	0.000268	CcSEcCtD
Phenylephrine—Nausea—Vinorelbine—hematologic cancer	0.000104	0.000266	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000104	0.000266	CcSEcCtD
Phenylephrine—Vomiting—Thalidomide—hematologic cancer	0.000103	0.000263	CcSEcCtD
Phenylephrine—Dizziness—Carmustine—hematologic cancer	0.000103	0.000263	CcSEcCtD
Phenylephrine—Pain—Etoposide—hematologic cancer	0.000103	0.000263	CcSEcCtD
Phenylephrine—Rash—Thalidomide—hematologic cancer	0.000102	0.000261	CcSEcCtD
Phenylephrine—Dermatitis—Thalidomide—hematologic cancer	0.000102	0.000261	CcSEcCtD
Phenylephrine—Dizziness—Alitretinoin—hematologic cancer	0.000102	0.000261	CcSEcCtD
Phenylephrine—Headache—Thalidomide—hematologic cancer	0.000101	0.000259	CcSEcCtD
Phenylephrine—Pain—Prednisolone—hematologic cancer	0.000101	0.000259	CcSEcCtD
Phenylephrine—Dizziness—Ifosfamide—hematologic cancer	0.000101	0.000258	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—hematologic cancer	9.95e-05	0.000255	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—hematologic cancer	9.93e-05	0.000255	CcSEcCtD
Phenylephrine—Nausea—Thiotepa—hematologic cancer	9.93e-05	0.000254	CcSEcCtD
Phenylephrine—Vomiting—Carmustine—hematologic cancer	9.87e-05	0.000253	CcSEcCtD
Phenylephrine—Dizziness—Vincristine—hematologic cancer	9.8e-05	0.000251	CcSEcCtD
Phenylephrine—Rash—Carmustine—hematologic cancer	9.79e-05	0.000251	CcSEcCtD
Phenylephrine—Dermatitis—Carmustine—hematologic cancer	9.78e-05	0.000251	CcSEcCtD
Phenylephrine—Vomiting—Alitretinoin—hematologic cancer	9.78e-05	0.000251	CcSEcCtD
Phenylephrine—Paraesthesia—Triamcinolone—hematologic cancer	9.78e-05	0.000251	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—hematologic cancer	9.75e-05	0.00025	CcSEcCtD
Phenylephrine—Headache—Carmustine—hematologic cancer	9.72e-05	0.000249	CcSEcCtD
Phenylephrine—Shock—Betamethasone—hematologic cancer	9.72e-05	0.000249	CcSEcCtD
Phenylephrine—Shock—Dexamethasone—hematologic cancer	9.72e-05	0.000249	CcSEcCtD
Phenylephrine—Dyspnoea—Triamcinolone—hematologic cancer	9.71e-05	0.000249	CcSEcCtD
Phenylephrine—Rash—Alitretinoin—hematologic cancer	9.7e-05	0.000248	CcSEcCtD
Phenylephrine—Nervous system disorder—Dexamethasone—hematologic cancer	9.69e-05	0.000248	CcSEcCtD
Phenylephrine—Nervous system disorder—Betamethasone—hematologic cancer	9.69e-05	0.000248	CcSEcCtD
Phenylephrine—Agitation—Prednisone—hematologic cancer	9.69e-05	0.000248	CcSEcCtD
Phenylephrine—Dermatitis—Alitretinoin—hematologic cancer	9.69e-05	0.000248	CcSEcCtD
Phenylephrine—Vomiting—Ifosfamide—hematologic cancer	9.66e-05	0.000248	CcSEcCtD
Phenylephrine—Hypersensitivity—Cisplatin—hematologic cancer	9.65e-05	0.000247	CcSEcCtD
Phenylephrine—Tachycardia—Dexamethasone—hematologic cancer	9.64e-05	0.000247	CcSEcCtD
Phenylephrine—Tachycardia—Betamethasone—hematologic cancer	9.64e-05	0.000247	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—hematologic cancer	9.64e-05	0.000247	CcSEcCtD
Phenylephrine—Headache—Alitretinoin—hematologic cancer	9.63e-05	0.000247	CcSEcCtD
Phenylephrine—Nausea—Thalidomide—hematologic cancer	9.6e-05	0.000246	CcSEcCtD
Phenylephrine—Rash—Ifosfamide—hematologic cancer	9.58e-05	0.000246	CcSEcCtD
Phenylephrine—Dermatitis—Ifosfamide—hematologic cancer	9.57e-05	0.000245	CcSEcCtD
Phenylephrine—Hyperhidrosis—Betamethasone—hematologic cancer	9.55e-05	0.000245	CcSEcCtD
Phenylephrine—Hyperhidrosis—Dexamethasone—hematologic cancer	9.55e-05	0.000245	CcSEcCtD
Phenylephrine—Dizziness—Irinotecan—hematologic cancer	9.54e-05	0.000245	CcSEcCtD
Phenylephrine—Urticaria—Etoposide—hematologic cancer	9.54e-05	0.000244	CcSEcCtD
Phenylephrine—Syncope—Prednisone—hematologic cancer	9.45e-05	0.000242	CcSEcCtD
Phenylephrine—Vomiting—Vincristine—hematologic cancer	9.42e-05	0.000241	CcSEcCtD
Phenylephrine—Urticaria—Prednisolone—hematologic cancer	9.41e-05	0.000241	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—hematologic cancer	9.39e-05	0.000241	CcSEcCtD
Phenylephrine—Rash—Vincristine—hematologic cancer	9.34e-05	0.000239	CcSEcCtD
Phenylephrine—Dermatitis—Vincristine—hematologic cancer	9.33e-05	0.000239	CcSEcCtD
Phenylephrine—Pain—Triamcinolone—hematologic cancer	9.31e-05	0.000239	CcSEcCtD
Phenylephrine—Headache—Vincristine—hematologic cancer	9.28e-05	0.000238	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—hematologic cancer	9.27e-05	0.000237	CcSEcCtD
Phenylephrine—Nausea—Carmustine—hematologic cancer	9.22e-05	0.000236	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—hematologic cancer	9.18e-05	0.000235	CcSEcCtD
Phenylephrine—Vomiting—Mitoxantrone—hematologic cancer	9.18e-05	0.000235	CcSEcCtD
Phenylephrine—Vomiting—Irinotecan—hematologic cancer	9.18e-05	0.000235	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—hematologic cancer	9.14e-05	0.000234	CcSEcCtD
Phenylephrine—Nausea—Alitretinoin—hematologic cancer	9.13e-05	0.000234	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—hematologic cancer	9.13e-05	0.000234	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—hematologic cancer	9.12e-05	0.000234	CcSEcCtD
Phenylephrine—Hypertension—Prednisone—hematologic cancer	9.1e-05	0.000233	CcSEcCtD
Phenylephrine—Rash—Mitoxantrone—hematologic cancer	9.1e-05	0.000233	CcSEcCtD
Phenylephrine—Rash—Irinotecan—hematologic cancer	9.1e-05	0.000233	CcSEcCtD
Phenylephrine—Dermatitis—Mitoxantrone—hematologic cancer	9.09e-05	0.000233	CcSEcCtD
Phenylephrine—Dermatitis—Irinotecan—hematologic cancer	9.09e-05	0.000233	CcSEcCtD
Phenylephrine—Headache—Irinotecan—hematologic cancer	9.04e-05	0.000232	CcSEcCtD
Phenylephrine—Headache—Mitoxantrone—hematologic cancer	9.04e-05	0.000232	CcSEcCtD
Phenylephrine—Nausea—Ifosfamide—hematologic cancer	9.03e-05	0.000231	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—hematologic cancer	8.94e-05	0.000229	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—hematologic cancer	8.92e-05	0.000229	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.91e-05	0.000228	CcSEcCtD
Phenylephrine—Paraesthesia—Betamethasone—hematologic cancer	8.87e-05	0.000227	CcSEcCtD
Phenylephrine—Paraesthesia—Dexamethasone—hematologic cancer	8.87e-05	0.000227	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—hematologic cancer	8.87e-05	0.000227	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—hematologic cancer	8.86e-05	0.000227	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—hematologic cancer	8.86e-05	0.000227	CcSEcCtD
Phenylephrine—Hypersensitivity—Etoposide—hematologic cancer	8.84e-05	0.000227	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—hematologic cancer	8.81e-05	0.000226	CcSEcCtD
Phenylephrine—Nausea—Vincristine—hematologic cancer	8.8e-05	0.000226	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—hematologic cancer	8.79e-05	0.000225	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisolone—hematologic cancer	8.72e-05	0.000224	CcSEcCtD
Phenylephrine—Urticaria—Triamcinolone—hematologic cancer	8.65e-05	0.000222	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—hematologic cancer	8.63e-05	0.000221	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—hematologic cancer	8.59e-05	0.00022	CcSEcCtD
Phenylephrine—Nausea—Mitoxantrone—hematologic cancer	8.57e-05	0.00022	CcSEcCtD
Phenylephrine—Nausea—Irinotecan—hematologic cancer	8.57e-05	0.00022	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—hematologic cancer	8.55e-05	0.000219	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—hematologic cancer	8.54e-05	0.000219	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.53e-05	0.000219	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.53e-05	0.000219	CcSEcCtD
Phenylephrine—Pruritus—Etoposide—hematologic cancer	8.49e-05	0.000218	CcSEcCtD
Phenylephrine—Shock—Prednisone—hematologic cancer	8.46e-05	0.000217	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—hematologic cancer	8.46e-05	0.000217	CcSEcCtD
Phenylephrine—Pain—Dexamethasone—hematologic cancer	8.45e-05	0.000216	CcSEcCtD
Phenylephrine—Pain—Betamethasone—hematologic cancer	8.45e-05	0.000216	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—hematologic cancer	8.45e-05	0.000216	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—hematologic cancer	8.44e-05	0.000216	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—hematologic cancer	8.4e-05	0.000215	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—hematologic cancer	8.36e-05	0.000214	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—hematologic cancer	8.35e-05	0.000214	CcSEcCtD
Phenylephrine—Vomiting—Cisplatin—hematologic cancer	8.33e-05	0.000213	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—hematologic cancer	8.32e-05	0.000213	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—hematologic cancer	8.3e-05	0.000213	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—hematologic cancer	8.3e-05	0.000213	CcSEcCtD
Phenylephrine—Rash—Cisplatin—hematologic cancer	8.26e-05	0.000212	CcSEcCtD
Phenylephrine—Dermatitis—Cisplatin—hematologic cancer	8.25e-05	0.000211	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—hematologic cancer	8.13e-05	0.000208	CcSEcCtD
Phenylephrine—Tension—Epirubicin—hematologic cancer	8.09e-05	0.000207	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—hematologic cancer	8.07e-05	0.000207	CcSEcCtD
Phenylephrine—Hypersensitivity—Triamcinolone—hematologic cancer	8.02e-05	0.000206	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—hematologic cancer	8.01e-05	0.000205	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—hematologic cancer	7.95e-05	0.000204	CcSEcCtD
Phenylephrine—Dizziness—Etoposide—hematologic cancer	7.94e-05	0.000203	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—hematologic cancer	7.92e-05	0.000203	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—hematologic cancer	7.9e-05	0.000202	CcSEcCtD
Phenylephrine—Urticaria—Dexamethasone—hematologic cancer	7.85e-05	0.000201	CcSEcCtD
Phenylephrine—Urticaria—Betamethasone—hematologic cancer	7.85e-05	0.000201	CcSEcCtD
Phenylephrine—Dizziness—Prednisolone—hematologic cancer	7.83e-05	0.000201	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—hematologic cancer	7.83e-05	0.000201	CcSEcCtD
Phenylephrine—Nausea—Cisplatin—hematologic cancer	7.78e-05	0.000199	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—hematologic cancer	7.77e-05	0.000199	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisone—hematologic cancer	7.73e-05	0.000198	CcSEcCtD
Phenylephrine—Pruritus—Triamcinolone—hematologic cancer	7.7e-05	0.000197	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—hematologic cancer	7.68e-05	0.000197	CcSEcCtD
Phenylephrine—Vomiting—Etoposide—hematologic cancer	7.63e-05	0.000196	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—hematologic cancer	7.58e-05	0.000194	CcSEcCtD
Phenylephrine—Rash—Etoposide—hematologic cancer	7.57e-05	0.000194	CcSEcCtD
Phenylephrine—Dermatitis—Etoposide—hematologic cancer	7.56e-05	0.000194	CcSEcCtD
Phenylephrine—Headache—Etoposide—hematologic cancer	7.52e-05	0.000193	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—hematologic cancer	7.5e-05	0.000192	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—hematologic cancer	7.49e-05	0.000192	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—hematologic cancer	7.47e-05	0.000191	CcSEcCtD
Phenylephrine—Rash—Prednisolone—hematologic cancer	7.47e-05	0.000191	CcSEcCtD
Phenylephrine—Dermatitis—Prednisolone—hematologic cancer	7.46e-05	0.000191	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.45e-05	0.000191	CcSEcCtD
Phenylephrine—Headache—Prednisolone—hematologic cancer	7.42e-05	0.00019	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—hematologic cancer	7.41e-05	0.00019	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—hematologic cancer	7.39e-05	0.000189	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—hematologic cancer	7.29e-05	0.000187	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—hematologic cancer	7.25e-05	0.000186	CcSEcCtD
Phenylephrine—Dizziness—Triamcinolone—hematologic cancer	7.2e-05	0.000184	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—hematologic cancer	7.19e-05	0.000184	CcSEcCtD
Phenylephrine—Nausea—Etoposide—hematologic cancer	7.13e-05	0.000183	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—hematologic cancer	7.12e-05	0.000182	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—hematologic cancer	7.05e-05	0.000181	CcSEcCtD
Phenylephrine—Nausea—Prednisolone—hematologic cancer	7.03e-05	0.00018	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—hematologic cancer	7.02e-05	0.00018	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—hematologic cancer	7.01e-05	0.00018	CcSEcCtD
Phenylephrine—Pruritus—Betamethasone—hematologic cancer	6.99e-05	0.000179	CcSEcCtD
Phenylephrine—Pruritus—Dexamethasone—hematologic cancer	6.99e-05	0.000179	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—hematologic cancer	6.98e-05	0.000179	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.97e-05	0.000179	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—hematologic cancer	6.95e-05	0.000178	CcSEcCtD
Phenylephrine—Vomiting—Triamcinolone—hematologic cancer	6.92e-05	0.000177	CcSEcCtD
Phenylephrine—Rash—Triamcinolone—hematologic cancer	6.86e-05	0.000176	CcSEcCtD
Phenylephrine—Dermatitis—Triamcinolone—hematologic cancer	6.86e-05	0.000176	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—hematologic cancer	6.84e-05	0.000175	CcSEcCtD
Phenylephrine—Urticaria—Prednisone—hematologic cancer	6.83e-05	0.000175	CcSEcCtD
Phenylephrine—Headache—Triamcinolone—hematologic cancer	6.82e-05	0.000175	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—hematologic cancer	6.74e-05	0.000173	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—hematologic cancer	6.7e-05	0.000172	CcSEcCtD
Phenylephrine—Shock—Epirubicin—hematologic cancer	6.62e-05	0.00017	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—hematologic cancer	6.6e-05	0.000169	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—hematologic cancer	6.59e-05	0.000169	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—hematologic cancer	6.57e-05	0.000168	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—hematologic cancer	6.54e-05	0.000167	CcSEcCtD
Phenylephrine—Dizziness—Dexamethasone—hematologic cancer	6.53e-05	0.000167	CcSEcCtD
Phenylephrine—Dizziness—Betamethasone—hematologic cancer	6.53e-05	0.000167	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—hematologic cancer	6.5e-05	0.000167	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—hematologic cancer	6.49e-05	0.000166	CcSEcCtD
Phenylephrine—Nausea—Triamcinolone—hematologic cancer	6.47e-05	0.000166	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—hematologic cancer	6.46e-05	0.000165	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.45e-05	0.000165	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—hematologic cancer	6.41e-05	0.000164	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisone—hematologic cancer	6.34e-05	0.000162	CcSEcCtD
Phenylephrine—Vomiting—Dexamethasone—hematologic cancer	6.28e-05	0.000161	CcSEcCtD
Phenylephrine—Vomiting—Betamethasone—hematologic cancer	6.28e-05	0.000161	CcSEcCtD
Phenylephrine—Rash—Betamethasone—hematologic cancer	6.23e-05	0.00016	CcSEcCtD
Phenylephrine—Rash—Dexamethasone—hematologic cancer	6.23e-05	0.00016	CcSEcCtD
Phenylephrine—Dermatitis—Dexamethasone—hematologic cancer	6.22e-05	0.000159	CcSEcCtD
Phenylephrine—Dermatitis—Betamethasone—hematologic cancer	6.22e-05	0.000159	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.21e-05	0.000159	CcSEcCtD
Phenylephrine—Headache—Betamethasone—hematologic cancer	6.19e-05	0.000159	CcSEcCtD
Phenylephrine—Headache—Dexamethasone—hematologic cancer	6.19e-05	0.000159	CcSEcCtD
Phenylephrine—Pain—Methotrexate—hematologic cancer	6.15e-05	0.000158	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—hematologic cancer	6.13e-05	0.000157	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—hematologic cancer	6.11e-05	0.000156	CcSEcCtD
Phenylephrine—Pruritus—Prednisone—hematologic cancer	6.09e-05	0.000156	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—hematologic cancer	6.08e-05	0.000156	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—hematologic cancer	6.05e-05	0.000155	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—hematologic cancer	6.04e-05	0.000155	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—hematologic cancer	6.02e-05	0.000154	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—hematologic cancer	6e-05	0.000154	CcSEcCtD
Phenylephrine—Nausea—Dexamethasone—hematologic cancer	5.87e-05	0.00015	CcSEcCtD
Phenylephrine—Nausea—Betamethasone—hematologic cancer	5.87e-05	0.00015	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.81e-05	0.000149	CcSEcCtD
Phenylephrine—Pain—Epirubicin—hematologic cancer	5.75e-05	0.000147	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—hematologic cancer	5.71e-05	0.000146	CcSEcCtD
Phenylephrine—Dizziness—Prednisone—hematologic cancer	5.69e-05	0.000146	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—hematologic cancer	5.59e-05	0.000143	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—hematologic cancer	5.55e-05	0.000142	CcSEcCtD
Phenylephrine—Vomiting—Prednisone—hematologic cancer	5.47e-05	0.00014	CcSEcCtD
Phenylephrine—Rash—Prednisone—hematologic cancer	5.42e-05	0.000139	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—hematologic cancer	5.42e-05	0.000139	CcSEcCtD
Phenylephrine—Headache—Prednisone—hematologic cancer	5.39e-05	0.000138	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.38e-05	0.000138	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—hematologic cancer	5.35e-05	0.000137	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—hematologic cancer	5.32e-05	0.000136	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—hematologic cancer	5.3e-05	0.000136	CcSEcCtD
Phenylephrine—Nausea—Prednisone—hematologic cancer	5.11e-05	0.000131	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—hematologic cancer	5.09e-05	0.00013	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—hematologic cancer	4.96e-05	0.000127	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—hematologic cancer	4.95e-05	0.000127	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—hematologic cancer	4.76e-05	0.000122	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—hematologic cancer	4.75e-05	0.000122	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—hematologic cancer	4.59e-05	0.000118	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—hematologic cancer	4.57e-05	0.000117	CcSEcCtD
Phenylephrine—Rash—Methotrexate—hematologic cancer	4.53e-05	0.000116	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—hematologic cancer	4.53e-05	0.000116	CcSEcCtD
Phenylephrine—Headache—Methotrexate—hematologic cancer	4.5e-05	0.000115	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—hematologic cancer	4.45e-05	0.000114	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—hematologic cancer	4.4e-05	0.000113	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—hematologic cancer	4.28e-05	0.00011	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—hematologic cancer	4.27e-05	0.000109	CcSEcCtD
Phenylephrine—Rash—Epirubicin—hematologic cancer	4.24e-05	0.000109	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—hematologic cancer	4.24e-05	0.000109	CcSEcCtD
Phenylephrine—Headache—Epirubicin—hematologic cancer	4.22e-05	0.000108	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—hematologic cancer	4.12e-05	0.000105	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—hematologic cancer	4e-05	0.000102	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—hematologic cancer	3.96e-05	0.000101	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—hematologic cancer	3.93e-05	0.000101	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—hematologic cancer	3.92e-05	0.0001	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—hematologic cancer	3.9e-05	9.99e-05	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—hematologic cancer	3.7e-05	9.48e-05	CcSEcCtD
Phenylephrine—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	1.29e-05	0.000123	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALOX5—hematologic cancer	1.29e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	1.29e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	1.28e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	1.28e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FOXO1—hematologic cancer	1.28e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGFR3—hematologic cancer	1.28e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—hematologic cancer	1.28e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFRB—hematologic cancer	1.27e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	1.27e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK14—hematologic cancer	1.26e-05	0.00012	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—hematologic cancer	1.26e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—hematologic cancer	1.26e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFRA—hematologic cancer	1.25e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JAK1—hematologic cancer	1.25e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCG—hematologic cancer	1.25e-05	0.000119	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NUP98—hematologic cancer	1.25e-05	0.000119	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—hematologic cancer	1.25e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—hematologic cancer	1.24e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	1.24e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	1.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	1.23e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FN1—hematologic cancer	1.22e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	1.21e-05	0.000116	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADCY7—hematologic cancer	1.21e-05	0.000115	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOA3—hematologic cancer	1.21e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BAD—hematologic cancer	1.21e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NFKBIA—hematologic cancer	1.21e-05	0.000115	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NUP214—hematologic cancer	1.2e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—hematologic cancer	1.2e-05	0.000114	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3R1—hematologic cancer	1.19e-05	0.000114	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.19e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD86—hematologic cancer	1.19e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	1.18e-05	0.000113	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTR—hematologic cancer	1.18e-05	0.000112	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.18e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CD80—hematologic cancer	1.17e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—hematologic cancer	1.17e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KIT—hematologic cancer	1.17e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NRAS—hematologic cancer	1.17e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HES1—hematologic cancer	1.17e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2RA—hematologic cancer	1.17e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	1.16e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—hematologic cancer	1.16e-05	0.00011	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO2—hematologic cancer	1.15e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—hematologic cancer	1.15e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTPN11—hematologic cancer	1.15e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	1.15e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	1.15e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	1.13e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	1.13e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	1.13e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFB—hematologic cancer	1.13e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—hematologic cancer	1.12e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	1.12e-05	0.000107	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.12e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CREB1—hematologic cancer	1.11e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	1.11e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	1.11e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	1.11e-05	0.000106	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.1e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—hematologic cancer	1.1e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TSC2—hematologic cancer	1.1e-05	0.000105	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—hematologic cancer	1.1e-05	0.000105	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SDC1—hematologic cancer	1.09e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—hematologic cancer	1.09e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6R—hematologic cancer	1.09e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CREBBP—hematologic cancer	1.09e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR3—hematologic cancer	1.06e-05	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK14—hematologic cancer	1.05e-05	0.0001	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.05e-05	9.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAP2K1—hematologic cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.03e-05	9.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—hematologic cancer	1.03e-05	9.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	1.03e-05	9.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—hematologic cancer	1.03e-05	9.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—hematologic cancer	1.02e-05	9.78e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—hematologic cancer	1.02e-05	9.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FN1—hematologic cancer	1.02e-05	9.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—hematologic cancer	1.01e-05	9.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BAD—hematologic cancer	1e-05	9.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NFKBIA—hematologic cancer	1e-05	9.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	1e-05	9.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—hematologic cancer	9.94e-06	9.48e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.87e-06	9.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGF2—hematologic cancer	9.86e-06	9.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	9.78e-06	9.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD80—hematologic cancer	9.74e-06	9.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3R1—hematologic cancer	9.72e-06	9.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—hematologic cancer	9.72e-06	9.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KIT—hematologic cancer	9.72e-06	9.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NRAS—hematologic cancer	9.72e-06	9.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTPN11—hematologic cancer	9.55e-06	9.11e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—hematologic cancer	9.51e-06	9.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JAK2—hematologic cancer	9.45e-06	9.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	9.4e-06	8.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	9.31e-06	8.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—hematologic cancer	9.31e-06	8.88e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD44—hematologic cancer	9.31e-06	8.88e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—hematologic cancer	9.31e-06	8.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—hematologic cancer	9.26e-06	8.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CREB1—hematologic cancer	9.25e-06	8.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MDM2—hematologic cancer	9.22e-06	8.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—hematologic cancer	9.14e-06	8.72e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	9.13e-06	8.71e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.11e-06	8.69e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—EP300—hematologic cancer	9.07e-06	8.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—hematologic cancer	9.05e-06	8.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6R—hematologic cancer	9.03e-06	8.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FN1—hematologic cancer	9.02e-06	8.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CREBBP—hematologic cancer	9.01e-06	8.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—hematologic cancer	8.97e-06	8.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—hematologic cancer	8.97e-06	8.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	8.91e-06	8.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BAD—hematologic cancer	8.91e-06	8.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	8.83e-06	8.42e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYCS—hematologic cancer	8.81e-06	8.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	8.75e-06	8.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD80—hematologic cancer	8.65e-06	8.25e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	8.63e-06	8.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KIT—hematologic cancer	8.63e-06	8.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	8.63e-06	8.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAP2K1—hematologic cancer	8.6e-06	8.21e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—hematologic cancer	8.57e-06	8.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—hematologic cancer	8.54e-06	8.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	8.48e-06	8.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—hematologic cancer	8.46e-06	8.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1B—hematologic cancer	8.42e-06	8.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—hematologic cancer	8.37e-06	7.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—hematologic cancer	8.33e-06	7.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	8.27e-06	7.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—hematologic cancer	8.25e-06	7.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—hematologic cancer	8.24e-06	7.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	8.22e-06	7.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—hematologic cancer	8.2e-06	7.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF2—hematologic cancer	8.18e-06	7.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	8.12e-06	7.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3R1—hematologic cancer	8.07e-06	7.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	8.04e-06	7.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—hematologic cancer	8.03e-06	7.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	8.02e-06	7.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUN—hematologic cancer	8.02e-06	7.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	8e-06	7.64e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.87e-06	7.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JAK2—hematologic cancer	7.84e-06	7.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—hematologic cancer	7.77e-06	7.42e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—hematologic cancer	7.76e-06	7.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—hematologic cancer	7.75e-06	7.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	7.69e-06	7.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	7.66e-06	7.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	7.64e-06	7.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	7.59e-06	7.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—hematologic cancer	7.59e-06	7.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—hematologic cancer	7.56e-06	7.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	7.52e-06	7.17e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.51e-06	7.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	7.45e-06	7.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	7.45e-06	7.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	7.43e-06	7.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EP300—hematologic cancer	7.4e-06	7.06e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—hematologic cancer	7.35e-06	7.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	7.27e-06	6.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—hematologic cancer	7.19e-06	6.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	7.17e-06	6.84e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOR1—hematologic cancer	7.13e-06	6.8e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—hematologic cancer	7.13e-06	6.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	7.11e-06	6.78e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	7e-06	6.68e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	6.99e-06	6.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	6.97e-06	6.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	6.93e-06	6.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	6.92e-06	6.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	6.91e-06	6.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	6.85e-06	6.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	6.84e-06	6.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	6.83e-06	6.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	6.81e-06	6.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	6.8e-06	6.49e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—hematologic cancer	6.71e-06	6.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	6.67e-06	6.36e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	6.65e-06	6.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	6.63e-06	6.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	6.62e-06	6.31e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	6.62e-06	6.31e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	6.45e-06	6.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—hematologic cancer	6.44e-06	6.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	6.44e-06	6.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	6.43e-06	6.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	6.32e-06	6.03e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—hematologic cancer	6.3e-06	6.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	6.3e-06	6.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	6.28e-06	5.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	6.21e-06	5.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	6.14e-06	5.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	6.14e-06	5.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	6.08e-06	5.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	6.08e-06	5.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	6.05e-06	5.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	5.97e-06	5.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	5.95e-06	5.68e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	5.92e-06	5.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	5.91e-06	5.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	5.81e-06	5.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	5.76e-06	5.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	5.74e-06	5.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	5.73e-06	5.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	5.72e-06	5.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	5.59e-06	5.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	5.58e-06	5.32e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.55e-06	5.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	5.5e-06	5.25e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—hematologic cancer	5.48e-06	5.23e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	5.47e-06	5.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	5.45e-06	5.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	5.35e-06	5.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	5.34e-06	5.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	5.3e-06	5.06e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	5.3e-06	5.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	5.29e-06	5.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	5.16e-06	4.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	5.11e-06	4.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	5.1e-06	4.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	5.06e-06	4.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	4.94e-06	4.72e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CREBBP—hematologic cancer	4.91e-06	4.68e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	4.88e-06	4.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	4.84e-06	4.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	4.75e-06	4.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	4.74e-06	4.52e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.66e-06	4.44e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—hematologic cancer	4.6e-06	4.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	4.54e-06	4.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	4.47e-06	4.26e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.4e-06	4.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	4.39e-06	4.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	4.39e-06	4.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	4.2e-06	4.01e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.06e-06	3.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	4.03e-06	3.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	4.02e-06	3.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	3.9e-06	3.72e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	3.73e-06	3.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	3.71e-06	3.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	3.57e-06	3.41e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—hematologic cancer	3.51e-06	3.35e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—EP300—hematologic cancer	3.34e-06	3.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	3.29e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.47e-06	2.36e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—hematologic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
